GHRP-6
First-Generation Growth Hormone Releasing Peptide
GHRP-6 is the original growth hormone releasing peptide — the first GHRP to demonstrate that GH could be stimulated via the ghrelin pathway without GHRH itself. Its 30+ year research history makes it the most characterized GHRP in terms of safety and pharmacokinetics, though its strong appetite stimulation has shifted most body composition research toward ipamorelin and GHRP-2.
At a Glance
GHRP-6's appetite stimulation — significant enough to double food intake in some animal models — was initially considered a disadvantage for body composition research. It has since become a research tool in its own right: studies of ghrelin's role in appetite, eating disorders, gastroparesis, and gut motility now use GHRP-6 specifically because of this effect.
Its gastroprotective properties are also well-documented — independent of its GH effects, GHRP-6 has shown cytoprotective effects in gastric and intestinal tissue models, placing it at an unexpected intersection with BPC-157's research territory.
For researchers studying the full ghrelin receptor cascade without selectivity filtering, GHRP-6 provides the most complete native-like ghrelin mimicry of all the GHRPs.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
GHSR-1a Full Agonism
Activates the ghrelin receptor (GHSR-1a) — including the appetite and gut motility signaling that more selective compounds like ipamorelin specifically avoid.
GH Release
Stimulates substantial GH release from the pituitary — the original demonstration that ghrelin-pathway GHRPs could drive GH secretion.
Appetite Stimulation
Strong ghrelin-mediated appetite stimulation — both a research confound in body composition studies and a specific research target in hunger and eating disorder models.
Gastroprotection
Independent cytoprotective effects on gastric and intestinal mucosa — studied in ulcer and gut injury models separate from GH effects.
- Original GHRP research — foundational compound for ghrelin receptor pharmacology
- Appetite and hunger studies — strong, reliable appetite stimulation model
- Gastroprotection — gastric mucosal protection independent of GH effects
- Gut motility research — ghrelin pathway involvement in gastric emptying
- Eating disorder models — ghrelin role in appetite dysregulation research
- GH release potency comparisons — baseline GHRP in secretagogue comparison studies
- Cachexia and wasting — appetite stimulation as therapeutic target in muscle wasting models
GHRP-6, GHRP-2, and ipamorelin define the full range of GHRP selectivity profiles — from complete ghrelin cascade activation to clean GH-only stimulation.
| Aspect | GHRP-6 | GHRP-2 | Ipamorelin |
|---|---|---|---|
| GH Release | Strong | Strongest | Moderate |
| Appetite Stimulation | Strong (significant) | Mild | None |
| Cortisol Release | Moderate | Moderate | Minimal |
| Selectivity | Lowest (full GHSR agonism) | Moderate | Highest |
| Best Research Use | Ghrelin cascade, appetite, gut | Potency / IGF-1 | Clean GH selectivity |
Longest research history — 30+ years of pharmacological characterization
Full ghrelin cascade model — for studies requiring the complete native receptor response
Dual utility — GH secretagogue and appetite/gut motility research tool
Strong appetite stimulation — confounds body composition studies unless controlled for; may be desired or undesired depending on research design
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026